A Web-based decision support platform to reduce non-evidence-based treatment of non-small cell lung cancer.

71 Background: Published reports indicate 30% to 40% of oncology treatments deviate from evidence-based standards. Little is known about the extent of deviation from guidelines in lung cancer. Methods: eviti is a web-based decision support platform that incorporates all recognized guidelines (ASCO, NCI, NCCN, ASTRO, and others) and supporting literature. An automated precertification code is issued if planned treatment is evidence-based and meets payer language. Variances may be discussed in a peer-to-peer (P2P) with staff oncologists. We analyzed all treatment plans submitted for patients with stage I to IV NSCLC between 1/1/2011 and 5/10/2012 to understand reasons for non-compliance with practice guidelines. There were seven payers with a total of 650,000 covered lives encompassing 43 states. Results: 561 treatment plans were submitted. 241 (43%) received an automatic code, and another 256 (46%) were given preauthorization codes after submission of medical records. 117 treatment plans required a P2P. 26...